2,154 research outputs found

    Impairment of the priming effect of glucose on insulin secretion from isolated islets of aging rats

    Get PDF
    The time-dependent potentiation (TDP) of insulin release or priming effect exerted by glucose was evaluated in the islets of Langerhans of mature and old rats. Islets isolated from 12- and 26-month-old male Sprague-Dawley rats and incubated for two consecutive 60-min periods in the presence of various stimulating agents were unable to enhance their insulin responsiveness significantly during the second incubation period and showed other abnormalities in their sensitivity to secretagogues compared with islets from 3-month-old animals. The priming action of glucose plus arginine or isobutylmethylxanthine (IBMX) was not observed in islets from 12-month-old rats, but surprisingly, islets from senescent rats showed a restoration of the beta-cell memory in the presence of IBMX. Interestingly, the islets isolated from 2-month-old animals previously exposed to an intravenous glucose load in vivo released approximately twice as much insulin as the islets taken from fed rats not subjected to the load. This potentiation exerted by the intravenous glucose administration was reduced but not abolished in the islets of glucose-intolerant, 12-month-old rats. In conclusion, the glucose TDP of insulin secretion is impaired in islets of mature and old rats, confirming an early loss of sensitivity of beta-cells to secretagogues during agin

    Protein glycation in the aging male Sprague-Dawley rat: effects of antiaging diet restrictions

    Get PDF
    Protein glycation and accumulation of advanced glycosylated end-products (AGEs) are supposed to play an important role in the process of aging. Dietary restriction increases life span and delays the onset of most age-associated diseases. Age-dependent changes in glucose homeostasis and glycated plasma proteins and hemoglobin were determined, and AGEs formation was measured as fluorescence in skin and aortic collagens in male Sprague-Dawley rats fed ad libitum or subjected to every-other-day feeding or 40% food restriction. In aging control rats, skin and aortic collagen-linked fluorescence increased with a similar exponential curve (aortic value being always higher), whereas glycated plasma protein and hemoglobin decreased slightly. Dietary restrictions decreased glycated plasma proteins and fluorescent products in skin collagen of younger but not older rats, and did not affect glycated hemoglobin or aortic collagen fluorescence. In conclusion, our data indicate that age-related changes in glucose homeostasis do not play a substantial role in aging; and collagen-linked fluorescence increases significantly during aging, but it may not be sensitive to dietary intervention

    High pT correlations with strange particles in STAR

    Full text link
    We present the highlights of the current identified strange particles DeltaPhi and DeltaEta correlations analyses, including system-size and trigger-pT of the jet and ridge, jet, ridge and away-side meson/baryon ratios, and the current state of the multi-strange baryon analysis. We see clear azimuthal peaks of comparable strength for all strange baryons and K0-short mesons. We see no observable species dependence on the same-side jet or ridge yields as a function of pT. However, while the away side and the ridge have Lambda to K0-short ratio similar to that of the bulk, the jet-only ratio is similar to that in p+pp+p. The implications of these findings on current in-medium jet theoretical explanations are discussed.Comment: Proceedings for the Strangeness in Quark Matter 2007 Conference in Levoca, Slovaki

    Effects of age, diet and obesity on insulin secretion from isolated perfused rat pancreas: Response to glucose, arginine and glucagon-like peptide 1 (7-37)

    Get PDF
    The insulin secretory responses to glucose, arginine and glucagon-like peptide (GLP)-1-(7- 37 have been evaluated from the isolated perfused pancreas of rats with either acquired or genetic obesity, ie, a) fed ad libitum 14-mo old Sprague-Dawley rats as compared to age-matched animals subjected to two types of dietary restriction (every-other-day feeding, EOD, and 40% restriction? 40% DR), and b) 2.5-mo old genetically obese fa/fa rats as compared to the lean counterpart, In mature fed ad libitum rats, the glucose-stimulated insulin release from the perfused pancreas was increased 5-fold by addition of 0.1 nM GLP-1 (7-37), a subsequent challenge with high glucose resulted in an improvement of the first phase of insulin release, In 40% DR rats, a similar pattern of secretion was observed, with the difference of a lower response to arginine than in fed ad libitum animals, In EOD rats, the overall secretory performance of the perfused pancreas was approximately 50% lower than in the fed ad libitum group but probably adequate to the reduced weight of the animals, In genetically obese young rats, both the response to GLP-1 (7-37) anti the total insulin secretion were higher than in the lean controls. Interestingly, the maximal insulin outputs from the perfused pancreases were observed in both the groups of overweight animals, In conclusion no impairment in the secretory responsiveness of beta-cells occurs in obese animals, Conversely, at least within the age limits of the present study, the endocrine pancreas develops a compensatory ability to match the augmented insulin demand due to the over-weight. In the light of the observed great sensitivity of the isolated perfused pancreas to GLP-1 (7-37), changes in the responsiveness of beta-cells to incretins might be involved in the modulation of the endocrine pancreatic function of obese rats

    Age-dependent reduction in GLUT-2 levels is correlated with the impairment of the insulin secretory response in isolated islets of Sprague-Dawley rats.

    Get PDF
    In this study we have investigated the insulin secretory response to glucose and other secretagogues (2-ketoisocaproate, 3-isobutyl-1-methyl-xanthine and arginine) of pancreatic islets isolated from Sprague-Dawley rats of various ages (from 2 to 28 months). Our results showed a significant decline in the glucose-stimulated insulin secretion, starting at 12 months of age. On the other hand, the response to non-glucose secretagogues (and mainly to 2-ketoisocaproate) was less impaired with advancing age than that to glucose. We also observed a progressive age-related decline of protein levels of the glucose transporter GLUT-2 in pancreatic islets, which was temporally concomitant and quantitatively comparable with the beta-cell alteration in glucose responsiveness (-40/50%). Finally, we observed a significant increase of the islets insulin content in older rats with respect to younger animals. We conclude that in the islet of older rats the impaired capability to respond to glucose could be dependent, at least in part, on the age-dependent reduction in GLUT-2 and could be compensated by mechanisms including a preserved responsiveness to non-glucose secretagogues and/or the development of islet hypertrophy

    Insufficient adaptive capability of pancreatic endocrine function in dexamethasone-treated ageing rats.

    Get PDF
    This study was aimed at exploring the capability of the pancreatic endocrine adaptive mechanisms of ageing Sprague-Dawley rats to counteract the metabolic challenge induced by the prolonged administration of dexamethasone (DEX) (0.13 mg/kg per day for 13 days). DEX treatment induced peripheral insulin resistance in 3-, 18- and 26-month-old rats, as indicated by the significant and persistent rise of plasma insulin levels in each age group (plasma insulin in 3-, 18- and 26-month-old rats from basal values of 4.3+/-0.8, 4.7+/-0.5 and 5.6+/-1.0 ng/ml (means+/-s.e.m.) respectively, rose to 11.9+/-1.7, 29.1+/-5.5 and 27.9+/-2.7 ng/ml respectively, after 9 days of administration). However, plasma glucose concentrations remained unchanged during the treatment in young rats, whereas they increased up to frankly diabetic levels in most 18-month-old and in all 26-month-old animals after a few days of DEX administration. Plasma free fatty acid concentrations increased 2-fold in 3- and 26-month-old rats and 4-fold in 18-month-old rats and could possibly be involved in the glucocorticoid-induced enhancement in insulin resistance, although they showed no significant correlation with glycaemic values. Incubation of pancreatic islets obtained from treated rats showed that DEX administration increased the insulin responsiveness of islets from not only younger but also older donors. However, in the islets of ageing rats, which already showed an age-dependent impairment of the sensitivity to glucose and other secretagogues, this enhancing effect was clearly attenuated with respect to the younger counterpart. Furthermore, DEX treatment depressed significantly the priming effect of glucose in islets isolated from all the three age groups. In conclusion, our results show that ageing rats are unable to counteract effectively a prolonged hyperglycaemic challenge as such induced by DEX administration. This homeostatic defect can be ascribed to the age-dependent failure of the endocrine pancreas to provide enough insulin to overcome the aggravation of an antecedent state of increased peripheral insulin resistance

    Age-dependent changes in insulin-like immunoreactivity in rat submandibular salivary glands.

    Get PDF
    In recent years, a growing interest had arisen in hormonal factors in salivary glands. We have investigated the changes in the content of an insulin-like immunoreactive (ILI) compound in the submandibular salivary glands of Sprague Dawley rats during physiological aging, in the range 15 days-27 months. The amount of ILI in the submandibular glands of young adult rats was found to be doubled in the post-natal period until the age of puberty and was maintained in senescence. No significant correlation was found between age-dependent variations in ILI levels of submandibular salivary glands and circulating insulin concentrations, further supporting previous indications that ILI is being synthesized in situ. It is possible that ILI could exert paracrine effects within the glands, as regards the development of other glandular structures during the first months of life, as well as the preservation of glandular function in senescent animals as well

    Energy and system dependence of high-pTp_T triggered two-particle near-side correlations

    Get PDF
    Previous studies have indicated that the near-side peak of high-pTp_T triggered correlations can be decomposed into two parts, the \textit{Jet} and the \textit{Ridge}. We present data on the yield per trigger of the \textit{Jet} and the \textit{Ridge} from d+Aud+Au, Cu+CuCu+Cu and Au+AuAu+Au collisions at sNN\sqrt{s_{NN}} = 62.4 GeV and 200 GeV and compare data on the \textit{Jet} to PYTHIA 8.1 simulations for p+pp+p. PYTHIA describes the \textit{Jet} component up to a scaling factor, meaning that PYTHIA can provide a better understanding of the \textit{Ridge} by giving insight into the effects of the kinematic cuts. We present collision energy and system dependence of the \textit{Ridge} yield, which should help distinguish models for the production mechanism of the \textit{Ridge}.Comment: 4 pages, 6 figures, proceedings for Hot Quarks in Estes Park, Colorad

    Effects of low-dose VOSO4 on age-related changes in glucose homeostasis in rats

    Get PDF
    The effects of low doses of vanadyl sulfate (0.2 mg/ml in the drinking water) on the age-related impairment of glucose homeostasis in Sprague-Dawley rats were investigated. VOSO(4) administration was initiated in 5-month-old animals and lasted 3 months. Thus, in 8-month-old rats, we investigated glucose metabolism in vivo and insulin secretory function in vitro. Results showed that VOSO(4) allowed the disposal of an oral glucose load at lower insulin levels than in age-matched controls. No significant changes were found in muscle glucose transporter (GLUT-4) levels or in glycogen content upon VOSO(4) treatment. Islets isolated from VOSO(4)-treated rats released less insulin than control islets, but showed a better preserved sensitivity to secretagogues, in terms of incremental release over basal release, secretory efficiency, and maintenance of the priming effect of glucose. In conclusion, chronic low-dose VOSO(4) treatment facilitates insulin action by a mechanism independent of muscle GLUT-4 levels and helps preserve the appropriate sensitivity of beta cells to stimuli, thereby preventing age-dependent functional alterations
    corecore